Former Fox News host Bill O'Reilly is offering more details about his health after announcing he paused various media endeavors to undergo treatment for an undisclosed illness. At the end of a column ...
Maintaining a Buy rating for Cipher Mining, driven by imminent HPC/AI lease revenues from AWS and Fluidstack starting in H2 2026. Cipher Mining projects ~$870 million in annual revenue and 76% blended ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cipher Mining (NasdaqGS:CIFR) is expanding into AI infrastructure through its first site ...
Xbox's family of transparent controllers is getting a new addition. The company has revealed a brand new Pulse Cipher Special Edition controller that has the same transparent design as its ...
For years, security teams treated ransomware as a technological problem. Security teams hardened backup systems, deployed endpoint detection, practiced incident response playbooks built around data ...
President Donald Trump touted "no tax on tips, no tax on overtime, no tax on Social Security" provisions from his "big beautiful bill" at a speech on Wednesday in Davos, Switzerland. Experts say the ...
Several House Democrats joined with nearly all Republicans to approve a bill funding the Department of Homeland Security (DHS) on Thursday, as anger grows over the Trump administration’s immigration ...
WASHINGTON — A sweeping government funding package is facing new hurdles in the Senate after another person was shot and killed by a federal officer on Saturday in Minnesota, raising the specter of a ...
Alaska U.S. House Rep. Nick Begich III has a new challenger. Bill Hill, a Bristol Bay fisherman and retired teacher and school administrator, filed to run for the congressional seat as an independent ...
The House on Thursday approved its final slate of 2026 funding bills, overcoming Democratic demands and GOP divisions and marking a significant milestone for Speaker Mike Johnson (R-La.) as he’s ...
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has shared its corporate updates and financial results for the fourth quarter and full year of 2024, highlighting significant advancements in its clinical ...